[BAX] Baxter International Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NYSE

The data is delayed by 15 minutes.

 

Price: 44.21 Change: 0.05 (0.11%)
Ext. hours: Change: 0 (0%)

chart BAX

Refresh chart

Strongest Trends Summary For BAX

BAX is in the medium-term up 16% above S&P in 6 months and up 41% in 1 year. In the long-term up 148% in 6 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Baxter International Inc. develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases, trauma, and other chronic and acute medical conditions. Its BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The company?s Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics; products and services related to pharmacy compounding, drug formulation, and packaging technologies; and technologies and therapies for peritoneal dialysis, in-center and home hemodialysis, and continuous renal replacement

Fundamental Ratios
Shares Outstanding EPS1.04 EPS Growth - 4 Quarters-41.96% EPS Growth - Q/Q-77.94%
EPS Growth - Y/Y41.76% Sales Growth - 4 Quarters -13.81% Sales Growth - Q/Q-15.83% P/E55.7
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA9.54% ROE32.67% ROI12.64%
Current Ratio1.6 Quick Ratio1.03 Long Term Debt/Equity2.1 Debt Ratio0.84
Gross Margin48.63% Operating Margin15.2% Net Profit Margin14.29% Dividend Payout Ratio-46.86%
Dividend Yield
Fundamental Data
Cash From Financing Activities384 M Cash From Investing Activities-770 M Cash From Operating Activities96 M Gross Profit1.92 B
Net Profit332 M Operating Profit435 M Total Assets24.86 B Total Current Assets9.73 B
Total Current Liabilities6.07 B Total Debt10.01 B Total Liabilities17.6 B Total Revenue3.89 B
Technical Data
High 52 week85.94 Low 52 week60.9 Last close85.75 Last change0.27%
RSI61.7 Average true range1.91 Beta0.59 Volume1.84 M
Simple moving average 20 days2.35% Simple moving average 50 days5.51% Simple moving average 200 days16.44%
Performance Data
Performance Week1.5% Performance Month4.17% Performance Quart13.53% Performance Half20.89%
Performance Year19.58% Performance Year-to-date31.32% Volatility daily1.28% Volatility weekly2.86%
Volatility monthly5.85% Volatility yearly20.28% Relative Volume171.45% Average Volume2.28 M
New High New Low

News

2019-10-14 06:53:46 | Should Baxter International Inc. NYSE:BAX Be Your Next Stock Pick?

2019-10-11 18:35:44 | Top Margin-Expanding Companies From the US and China

2019-10-10 12:52:00 | Baxter Recognized as One of 2019 'Best Companies for Dads’ by Working Mother

2019-10-10 09:30:01 | HRC or BAX: Which Is the Better Value Stock Right Now?

2019-10-09 15:42:31 | 6 Companies That Are Expected to Grow Quickly

2019-10-08 07:04:11 | Stryker Gains From Flagship Mako and Broad Product Spectrum

2019-10-02 09:48:01 | Abbott ABT Gets FDA Nod for New Troponin-I Blood Test

2019-10-01 06:30:00 | Baxter Home Dialysis Study Associates Sharesource With 39% Reduction in Hospitalization Rates for Colombian Patients

2019-09-27 10:08:02 | Haemonetics Grows on Strong Plasma, Hemostasis Management

2019-09-27 06:38:59 | A Look At The Fair Value Of Baxter International Inc. NYSE:BAX

2019-09-26 16:15:00 | Baxter Features Patient-Centered Innovation at the 2019 European Society of Intensive Care Medicine Congress

2019-09-26 04:00:00 | Early and Effective Nutritional Therapy in GI Cancer Patients: An Opportunity to Improve Patient Outcomes & Quality of Life

2019-09-24 11:12:03 | Here's Why You Should Hold on to Wright Medical WMGI Stock

2019-09-23 19:17:48 | Investors May Want to Follow the Progress of These Biotechs

2019-09-23 11:25:03 | Illumina ILMN Gains on Product Pipeline, Global Footprint

2019-09-23 11:18:03 | Medtronic's MiniMed 670G Shows Favorable Outcome in Europe

2019-09-23 11:09:03 | Here's Why You Should Hold on to Nevro NVRO Stock for Now

2019-09-20 11:56:03 | QIAGEN QGEN Hurt by Low QuantiFERON-TB Sales & FX Headwind

2019-09-20 10:57:02 | Fresenius Medical Launches 4008A Dialysis Machine in China

2019-09-20 08:45:12 | Align Technology Inks Distribution Deal With Zimmer Biomet

2019-09-19 10:25:02 | PRA Health Simplifies Treatment Decisions With Metys Launch

2019-09-19 09:55:01 | Tandem Diabetes Posts Positive Data on t:slim X2 With Basal-IQ

2019-09-18 11:16:03 | Here's Why You Should Retain Globus Medical GMED Stock Now

2019-09-18 09:59:01 | Here's Why You Should Retain Pacific Biosciences For Now

2019-09-18 09:25:01 | Accuray's ARAY CyberKnife Delivers Improved Patient Outcome

2019-09-18 09:22:01 | Zimmer Biomet's New JuggerStitch to Grow Sports Medicine Line

2019-09-18 07:57:11 | Abbott Receives European Nod for Pediatric Heart Devices

2019-09-17 11:07:03 | Intersect ENT Rides on Innovation Amid Pricing Concerns

2019-09-17 10:18:02 | HMS Holdings Acquires VitreosHealth, Boosts PHM Solution Set

2019-09-17 10:00:02 | Here's Why You Should Retain OPKO Health OPK Stock For Now

2019-09-17 09:54:01 | Varian's ProBeam Now Available in Multi-Room Configuration

2019-09-17 09:52:01 | Medtronic Collaborates With Novo Nordisk for Diabetes Care

2019-09-16 10:43:46 | Zacks.com featured highlights include: Medtronic, Symantec, Target, Popular and Baxter International

2019-09-16 09:47:01 | Here's Why You Should Retain Patterson Companies PDCO Now

2019-09-16 08:30:00 | Baxter Named to 2019 Dow Jones Sustainability Indices

2019-09-16 08:29:12 | Abbott's ABT FreeStyle Libre Gains Canadian Reimbursement

2019-09-16 08:26:12 | Medtronic MDT Earns Dow Jones Sustainability Recognition

2019-09-16 08:09:12 | BioSig Technologies-Mayo Clinic Ink Electrophysiology Deal

2019-09-13 10:54:02 | Walgreens' Retail Pharmacy Stays Firm Amid Reimbursement Woes

2019-09-13 09:40:01 | BAX or BSX: Which Is the Better Value Stock Right Now?

2019-09-13 09:07:01 | CryoLife Enters Agreement With Endospan for Aortic Stent

2019-09-13 08:16:12 | Medidata MDSO Collaborates With Mapi Research to Boost Rave

2019-09-12 11:09:03 | Ecolab's ECL Nalco Water Opens Customer Experience Center

2019-09-12 10:52:02 | Here's Why You Should Hold on to Ecolab ECL Stock Now

2019-09-12 10:10:02 | 5 High-Flying Stocks Near 52-Week High That Can Scale Higher

2019-09-12 09:09:01 | Bruker BRKR Introduces the nanoIR3-s Broadband System

2019-09-11 11:27:03 | Integra Buys Rebound Therapeutics to Boost Neurosurgery Line

2019-09-11 09:04:01 | Baxter's BAX Cheetah Acquisition to Aid Patient Monitoring

2019-09-10 14:36:22 | Could Baxter International Inc.'s NYSE:BAX Investor Composition Influence The Stock Price?

2019-09-10 11:33:03 | GNC Holdings Rides on New Pacts Amid Weak Same Store Sales